Wenzhou Ding

783 total citations
22 papers, 403 citations indexed

About

Wenzhou Ding is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenzhou Ding has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Wenzhou Ding's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Wenzhou Ding is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Wenzhou Ding collaborates with scholars based in China, United Kingdom and Taiwan. Wenzhou Ding's co-authors include Yongping Zhou, Zhiyuan Hua, Wei Qian, Junsheng Fan, Sijin Cheng, Guoyong Han, Qingfeng Ni, Lianbao Kong, Jindao Wu and Liangliang Kong and has published in prestigious journals such as PLoS ONE, Journal of Cellular Physiology and International Journal of Biological Macromolecules.

In The Last Decade

Wenzhou Ding

17 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenzhou Ding China 8 183 182 143 73 67 22 403
Shaoyong Peng China 13 193 1.1× 161 0.9× 159 1.1× 82 1.1× 57 0.9× 24 437
Snahlata Singh India 11 246 1.3× 148 0.8× 205 1.4× 45 0.6× 103 1.5× 14 468
Yifei Mu China 14 228 1.2× 133 0.7× 140 1.0× 43 0.6× 94 1.4× 27 457
Long Feng China 11 220 1.2× 136 0.7× 76 0.5× 36 0.5× 59 0.9× 44 360
Yun‐Kai Lin China 11 190 1.0× 108 0.6× 90 0.6× 74 1.0× 73 1.1× 15 340
Kin‐Fai Cheung Hong Kong 6 267 1.5× 120 0.7× 110 0.8× 63 0.9× 34 0.5× 7 394
Xuanfu Xu China 13 367 2.0× 156 0.9× 161 1.1× 39 0.5× 64 1.0× 19 499
Wei Wen China 11 179 1.0× 127 0.7× 90 0.6× 60 0.8× 39 0.6× 25 350
Hugues de Boussac France 13 214 1.2× 94 0.5× 107 0.7× 120 1.6× 35 0.5× 27 382

Countries citing papers authored by Wenzhou Ding

Since Specialization
Citations

This map shows the geographic impact of Wenzhou Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenzhou Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenzhou Ding more than expected).

Fields of papers citing papers by Wenzhou Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenzhou Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenzhou Ding. The network helps show where Wenzhou Ding may publish in the future.

Co-authorship network of co-authors of Wenzhou Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Wenzhou Ding. A scholar is included among the top collaborators of Wenzhou Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenzhou Ding. Wenzhou Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Litao, et al.. (2025). LRP11 facilitates lipid metabolism and malignancy in hepatocellular carcinoma by stabilizing RACK1 through USP5 regulation. Molecular Medicine. 31(1). 35–35. 1 indexed citations
2.
Ding, Wenzhou, et al.. (2025). Liver X Receptor Activation Alleviates Hepatic Ischemia‐Reperfusion Injury in Diabetes by Inhibiting NF‐κB–NLRP3 Activation. Immunity Inflammation and Disease. 13(8). e70243–e70243.
3.
Yang, Weiming, Zhijie Ding, Litao Liang, et al.. (2025). Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8 + T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 13(10). e012314–e012314.
4.
5.
Xu, Bin, Yanzhi Feng, Litao Liang, et al.. (2024). BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance. Cancer Gene Therapy. 31(12). 1868–1883.
6.
Feng, Yanzhi, Litao Liang, Bin Xu, et al.. (2024). Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis. Journal of Hepatocellular Carcinoma. Volume 11. 1095–1112. 4 indexed citations
7.
Xu, Bin, Yanzhi Feng, Litao Liang, et al.. (2024). HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA. International Journal of Biological Sciences. 20(13). 5087–5108. 3 indexed citations
8.
Xu, Bin, Wenbo Jia, Yanzhi Feng, et al.. (2023). Exosome-transported circHDAC1_004 Promotes Proliferation, Migration, and Angiogenesis of Hepatocellular Carcinoma by the miR-361-3p/NACC1 Axis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 5 indexed citations
9.
Chen, Zhiqiang, Xueliang Zuo, Juan Cai, et al.. (2023). Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma. Experimental Hematology and Oncology. 12(1). 17–17. 54 indexed citations
10.
Chen, Zhiqiang, Xueliang Zuo, Yao Zhang, et al.. (2023). Derivation and validation of machine learning models for preoperative estimation of microvascular invasion risk in hepatocellular carcinoma. Annals of Translational Medicine. 11(6). 249–249. 1 indexed citations
11.
Zhao, Jie, Yongzhong Guo, Wenzhou Ding, et al.. (2022). Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study. Frontiers in Oncology. 12. 965711–965711.
12.
Ding, Wenzhou, Ye Fan, Xiongxiong Pan, et al.. (2021). FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling. Frontiers in Oncology. 11. 683878–683878. 10 indexed citations
13.
Wu, Jindao, Wenzhou Ding, Guoyong Han, et al.. (2020). Nuclear delivery of dual anti-cancer drugs by molecular self-assembly. Biomaterials Science. 9(1). 116–123. 5 indexed citations
14.
Zhao, Hui, Wenzhou Ding, Hong Wang, et al.. (2020). Prognostic value of precise hepatic pedicle dissection in anatomical resection for patients with hepatocellular carcinoma. Medicine. 99(10). e19475–e19475. 6 indexed citations
15.
Zhou, Yongping, Wei Qian, Junsheng Fan, et al.. (2018). Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Clinica Chimica Acta. 479. 181–189. 113 indexed citations
16.
Ding, Wenzhou, et al.. (2018). Anti‑IL‑20 monoclonal antibody suppresses hepatocellular carcinoma progression. Oncology Letters. 16(5). 6156–6162. 6 indexed citations
17.
Lu, Sen, Jindao Wu, Yuanyuan Gao, et al.. (2016). MicroRNA-4262 activates the NF-κB and enhances the proliferation of hepatocellular carcinoma cells. International Journal of Biological Macromolecules. 86. 43–49. 29 indexed citations
18.
Ding, Wenzhou, et al.. (2015). MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma. Oncology Letters. 11(2). 1081–1088. 11 indexed citations
19.
Ni, Qingfeng, et al.. (2014). Latexin exhibits tumor suppressor potential in hepatocellular carcinoma. Oncology Reports. 31(3). 1364–1372. 20 indexed citations
20.
Jiang, Weiwei, Liangliang Kong, Qingfeng Ni, et al.. (2014). miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6. PLoS ONE. 9(7). e101530–e101530. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaoyong Peng Breakdown of academic impact, for papers by Snahlata Singh Breakdown of academic impact, for papers by Yifei Mu Breakdown of academic impact, for papers by Long Feng Breakdown of academic impact, for papers by Yun‐Kai Lin Breakdown of academic impact, for papers by Kin‐Fai Cheung Breakdown of academic impact, for papers by Xuanfu Xu Breakdown of academic impact, for papers by Wei Wen Breakdown of academic impact, for papers by Hugues de Boussac
Rankless by CCL
2026